Comparable stake leader
PERCEPTIVE ADVISORS LLC
SEC ownership of VBI Vaccines Inc/BC
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0000764195.
Disclosed value leader
PERCEPTIVE ADVISORS LLC
Comparable rows
0/15
Latest evidence
27 Jul 2023
- Parsed ownership sources
-
3/4/5
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
PERCEPTIVE ADVISORS LLC
Ranking: Comparable ownership first, then disclosed value
- Latest parsed ownership date
-
27 Jul 2023
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0000764195
- Issuer location
- Cambridge, MA
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
1 signal
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of VBI Vaccines Inc/BC (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
PERCEPTIVE ADVISORS LLC
Disclosed value leader
PERCEPTIVE ADVISORS LLC
Comparable rows
0/15
Latest evidence
27 Jul 2023
3/4/5
Highest disclosed value: $137,168,813
15 rows are not safely comparable across share classes.
Showing 1-8 of 15 holder rows.
Quick read
PERCEPTIVE ADVISORS LLC has the largest disclosed position value at $137.17M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens PERCEPTIVE ADVISORS LLC's linked filing trail.
Disclosed position value
Top 2
PERCEPTIVE ADVISORS LLC
$137.17M
Steven Gillis
$1.73M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-8 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| PERCEPTIVE ADVISORS LLC |
3/4/5
10%+ Owner
|
—
class O/S missing
|
$137,168,813
41,440,729 shares
|
— | 04 Apr 2023 |
| Steven Gillis |
3/4/5
Director
|
—
mixed-class rows
|
$1,726,075
1,707,696 shares
mixed-class rows
|
— | 27 Jul 2023 |
| Christopher McNulty |
3/4/5
CFO and Head of BD, Director
|
—
class O/S missing
|
—
75,000 shares
|
— | 26 Jan 2023 |
| Linda Bain |
3/4/5
Director
|
—
class O/S missing
|
—
75,000 shares
|
— | 27 Jan 2022 |
| Jeff Baxter |
3/4/5
CEO, President, Director
|
—
class O/S missing
|
—
70,000 shares
|
— | 27 Jul 2023 |
| Avi Mazaltov |
3/4/5
Head Global MFG&GM-SciVac Ltd.
|
—
class O/S missing
|
—
52,500 shares
|
— | 27 Jul 2023 |
| David Evander Anderson |
3/4/5
Chief Scientific Officer
|
—
class O/S missing
|
—
52,500 shares
|
— | 27 Jul 2023 |
| Francisco Diaz-Mitoma |
3/4/5
Chief Medical Officer
|
—
class O/S missing
|
—
52,500 shares
|
— | 27 Jul 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 13 Sep 2025.
Buys
$0
Insiders: 0
Sells
$0
Insiders: 0
Net
$0
Shares: 0
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 0
Shares: 0
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-15 of 15 reporting-owner rows connected to VBI Vaccines Inc/BC. Open a relationship link for the CIK-to-CIK filing trail.
Rows
15
Largest Forms 3/4/5 holder
PERCEPTIVE ADVISORS LLC
Net 12M change
$0
Latest report
27 Jul 2023
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| PERCEPTIVE ADVISORS LLC | 10%+ Owner | $137,168,813 | Mixed | 04 Apr 2023 | ||
| Steven Gillis | Director | $1,726,075 | Mixed | 27 Jul 2023 | ||
| Jeff Baxter | CEO, President, Director | Mixed | 27 Jul 2023 | |||
| Vaughn B. Himes | Director | Mixed | 27 Jul 2023 | |||
| Linda Bain | Director | Mixed | 27 Jan 2022 | |||
| Michel DeWilde | Director | Mixed | 27 Jul 2023 | |||
| Francisco Diaz-Mitoma | Chief Medical Officer | Mixed | 27 Jul 2023 | |||
| Nell Beattie | CFO, Head of Corp. Development, Director | Mixed | 27 Jul 2023 | |||
| Avi Mazaltov | Head Global MFG&GM-SciVac Ltd. | Mixed | 27 Jul 2023 | |||
| Blaine H. McKee | Director | Mixed | 27 Jul 2023 | |||
| John Robert Dillman | Chief Commercial Officer | Mixed | 27 Jul 2023 | |||
| Damian Braga | Director | Mixed | 27 Jul 2023 | |||
| Christopher McNulty | CFO and Head of BD, Director | Mixed | 26 Jan 2023 | |||
| David Evander Anderson | Chief Scientific Officer | Mixed | 27 Jul 2023 | |||
| Joanne Cordeiro | Director | Mixed | 27 Jul 2023 |
Recent insider transactions for VBI Vaccines Inc/BC
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| No insider transactions were found in the last 12 months for this issuer. | ||||||||||
* marks a reported price that did not pass the local price check.